Literature DB >> 1424068

Ordering respiratory care services for hospitalized patients: practices of overuse and underuse.

L Kester1, J K Stoller.   

Abstract

Because of recent concerns about misallocation of respiratory care services and analyses suggesting that limiting services to comply with established guidelines reduces unneeded therapies without compromising quality of care, the authors audited the records of 170 patients newly ordered to receive at least one of five respiratory therapies (oxygen therapy, incentive spirometry, bronchopulmonary hygiene, aerosolized bronchodilator therapy, or intermittent positive pressure breathing) at The Cleveland Clinic Foundation. In reviewing whether the therapies that were ordered complied with published guidelines for these services, we found that 25.2% were "not indicated." This over-ordering incurred unnecessary total charges of $11,937 ($206.16 per patient) and occupied therapist time that could have been better allocated to other services. These costs were offset by the finding that 10.5% of the patients were not ordered to receive indicated respiratory therapies. Our proposed strategy of initiating protocols for ordering and providing respiratory care services (ie, via a respiratory care consult service) is an appealing means to address this misallocation, but it requires further evaluation.

Entities:  

Mesh:

Year:  1992        PMID: 1424068     DOI: 10.3949/ccjm.59.6.581

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  4 in total

1.  Respiratory therapist-driven protocols.

Authors:  L Zimmerman
Journal:  West J Med       Date:  1997-12

2.  Respiratory therapist-driven protocols. Rationale and efficacy.

Authors:  J K Stoller
Journal:  West J Med       Date:  1997-12

3.  Development, dissemination, implementation and evaluation of a clinical pathway for oxygen therapy.

Authors:  C Wong; F Visram; D Cook; L Griffith; J Randall; B O'Brien; D Higgins
Journal:  CMAJ       Date:  2000-01-11       Impact factor: 8.262

4.  Developing a formal representation for medication appropriateness criteria.

Authors:  Hojjat Salmasian; Tran H Tran; Carol Friedman
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.